Lodz, Poland

Michal C Piotrowicz



 

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Łódź, PL (2019)
  • Lodz, PL (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michal C Piotrowicz: Innovator in Chitinase Inhibitors

Introduction

Michal C Piotrowicz is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target human chitinase. With a total of 2 patents, his work is paving the way for new therapeutic approaches.

Latest Patents

One of his latest patents involves substituted amino triazoles that serve as human chitinase inhibitors. These compounds are characterized by a piperidinyl ring that is further substituted with a heterocyclic ring. The invention details methods for using these compounds to treat various conditions, including asthma reactions caused by allergens, acute and chronic inflammatory diseases, autoimmune diseases, dental diseases, neurologic diseases, metabolic diseases, liver diseases, polycystic ovary syndrome, endometriosis, and cancer.

Career Highlights

Michal C Piotrowicz is currently associated with Oncoarendi Therapeutics S.A., where he continues to innovate in the field of drug development. His research focuses on creating effective treatments that can address complex health issues.

Collaborations

He collaborates with talented professionals such as Marzena Mazur and Robert Koralewski, contributing to a dynamic research environment that fosters innovation.

Conclusion

Michal C Piotrowicz's work in developing chitinase inhibitors represents a significant advancement in therapeutic options for various diseases. His contributions are essential in the ongoing quest for effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…